Related references
Note: Only part of the references are listed.Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors
Abigail K. Grosskopf et al.
SCIENCE ADVANCES (2022)
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson et al.
NATURE REVIEWS CANCER (2021)
Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds
David K. Y. Zhang et al.
NATURE PROTOCOLS (2020)
Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
Hillary G. Caruso et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Programming CAR-T cells to kill cancer
Louai Labanieh et al.
NATURE BIOMEDICAL ENGINEERING (2018)
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites
Aleksei Titov et al.
CELL DEATH & DISEASE (2018)
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
Somala Mohammed et al.
MOLECULAR THERAPY (2017)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
Thomas A. Waldmann et al.
BLOOD (2011)
Share Paper
